NewsDesk @bactiman63 The first country-wide mass drug administration in the world for the treatment of scabies is happening in the Solomon Islands. The World Scabies Program is spearheading the mass drug...

NewsDesk @bactiman63 An anti-parasitic drug will be rolled out on mass scale in the Solomon Islands to prevent scabies, a contagious, intensely itchy skin condition that affects a third of the nation’s...

NewsDesk @bactiman63 Ivermectin is a drug approved by the United States Food and Drug Administration (FDA) to treat parasites in animals and in humans with intestinal strongyloidiasis (roundworm) and onchocerciasis (river...

NewsDesk @bactiman63 One dose of an anti-parasite drug was just as effective as two at significantly reducing the spread of scabies, the contagious, intensely itchy skin condition, according to a new...

NewsDesk  @infectiousdiseasenews The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe...

NewsDesk  @infectiousdiseasenews In this post, an annual tradition, I want to recognize the Top 10 most popular posts of the year on the website based on the amount of traffic received starting at number...

NewsDesk  @infectiousdiseasenews Combining two agents to block a parasitic worm’s life cycle boosted survival from a potentially deadly tropical disease to 85% in animal models, far better than either...

By NewsDesk  @bactiman63 Researchers at the University of California, Davis and Colorado State University presented evidence at the ASTMH Annual Meeting that adding ivermectin to backyard bird feeders...

By NewsDesk  @infectiousdiseasenews New data indicate that mass treatment with ivermectin—a drug that was a workhorse of tropical medicine long before it emerged as a controversial COVID-19 treatment—has...

NewsDesk @bactiman63 The Institute for Clinical Research (ICR) NIH today announced findings for the Ivermectin study (I-TECH) in 500 hospitalised patients with Stage 2 or 3 COVID-19. This multi-centre...